Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS

[1]  J. Coresh,et al.  Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate. , 2016, Kidney international.

[2]  J. Hoekman,et al.  Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis. , 2015, Journal of the American Society of Nephrology : JASN.

[3]  M. Woodward,et al.  Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  A. Cheung,et al.  GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  C. Schmid,et al.  GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  J. Coresh,et al.  GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  B. Zinman,et al.  Renal outcomes in patients with type 1 diabetes and macroalbuminuria. , 2014, Journal of the American Society of Nephrology : JASN.

[8]  Mark E Molitch,et al.  Diabetic Kidney Disease: A Report From an ADA Consensus Conference , 2014, Diabetes Care.

[9]  J. Coresh,et al.  Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.

[10]  K. Kimura.  Preface: evidence-based clinical practice guidelines for CKD—an abridged English version , 2014, Clinical and Experimental Nephrology.

[11]  S. Kaneko,et al.  Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency , 2014, Clinical and Experimental Nephrology.

[12]  T. Ninomiya,et al.  Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes , 2014, Clinical and Experimental Nephrology.

[13]  S. Kaneko,et al.  Long-Term Outcomes of Japanese Type 2 Diabetic Patients With Biopsy-Proven Diabetic Nephropathy , 2013, Diabetes Care.

[14]  R. MacIsaac,et al.  Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function , 2013, Diabetes Care.

[15]  J. Chan,et al.  Reduction and residual proteinuria are therapeutic targets in type 2 diabetes with overt nephropathy: a post hoc analysis (ORIENT-proteinuria). , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  H. Yokoyama,et al.  Association Between Remission of Macroalbuminuria and Preservation of Renal Function in Patients With Type 2 Diabetes With Overt Proteinuria , 2013, Diabetes Care.

[17]  S. Kaneko,et al.  Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation , 2013, Clinical and Experimental Nephrology.

[18]  J. Skupień,et al.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.

[19]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[20]  T. Hasegawa,et al.  An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007) , 2009, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[21]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  E. Lewis,et al.  Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  Zhongxin Zhang,et al.  Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. , 2004, Kidney international.

[24]  M. Mauer,et al.  Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. , 2003, Diabetes.

[25]  H. Parving,et al.  Remission of nephrotic-range albuminuria in type 1 diabetic patients. , 2001, Diabetes care.

[26]  T. Nishino,et al.  Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  Japanese Society of Nephrology.  Evidence-based Clinical Practice Guideline for CKD 2013 , 2014, Clinical and Experimental Nephrology.